Tower View Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56K | Hold |
112
| – | – | 0.02% | 99 |
|
|
2026
Q1 | $54.8K | Sell |
112
-11
| -9% | -$5.97K | 0.03% | 93 |
|
|
2025
Q4 | $71.5K | Hold |
123
| – | – | 0.04% | 80 |
|
|
2025
Q3 | $59.8K | Sell |
123
-52
| -30% | -$24.2K | 0.03% | 79 |
|
|
2025
Q2 | $70.8K | Buy |
175
+1
| +0.6% | +$418 | 0.04% | 90 |
|
|
2025
Q1 | $86.8K | Sell |
174
-87
| -33% | -$47.1K | 0.05% | 64 |
|
|
2024
Q4 | $136K | Sell |
261
-2
| -0.8% | -$1.1K | 0.07% | 63 |
|
|
2024
Q3 | $163K | Hold |
263
| – | – | 0.09% | 58 |
|
|
2024
Q2 | $145K | Buy |
263
+26
| +11% | +$14.9K | 0.08% | 60 |
|
|
2024
Q1 | $138K | Hold |
237
| – | – | 0.08% | 66 |
|
|
2023
Q4 | $126K | Hold |
237
| – | – | 0.08% | 62 |
|
|
2023
Q3 | $120K | Hold |
237
| – | – | 0.08% | 62 |
|
|
2023
Q2 | $124K | Hold |
237
| – | – | 0.08% | 61 |
|
|
2023
Q1 | $136K | Hold |
237
| – | – | 0.09% | 65 |
|
|
2022
Q4 | $130K | Hold |
237
| – | – | 0.09% | 64 |
|
|
2022
Q3 | $120K | Buy |
237
+1
| +0.4% | +$560 | 0.09% | 66 |
|
|
2022
Q2 | $128K | Sell |
236
-17
| -7% | -$9.36K | 0.09% | 67 |
|
|
2022
Q1 | $150K | Hold |
253
| – | – | 0.08% | 81 |
|
|
2021
Q4 | $169K | Hold |
253
| – | – | 0.09% | 81 |
|
|
2021
Q3 | $145K | Hold |
253
| – | – | 0.08% | 79 |
|
|
2021
Q2 | $128K | Hold |
253
| – | – | 0.06% | 85 |
|
|
2021
Q1 | $115K | Buy |
253
+17
| +7% | +$8.11K | 0.06% | 89 |
|
|
2020
Q4 | $110K | Hold |
236
| – | – | 0.06% | 87 |
|
|
2020
Q3 | $104K | Sell |
236
-15
| -6% | -$6.2K | 0.07% | 78 |
|
|
2020
Q2 | $91K | Sell |
251
-9
| -3% | -$3.02K | 0.07% | 75 |
|
|
2020
Q1 | $74K | Sell |
260
-15
| -5% | -$4.73K | 0.07% | 69 |
|
|
2019
Q4 | $89K | Hold |
275
| – | – | 0.07% | 74 |
|
|
2019
Q3 | $80K | Hold |
275
| – | – | 0.07% | 74 |
|
|
2019
Q2 | $81K | Hold |
275
| – | – | 0.07% | 69 |
|
|
2019
Q1 | $75K | Buy |
275
+57
| +26% | +$14.2K | 0.07% | 70 |
|
|
2018
Q4 | $49K | Hold |
218
| – | – | 0.05% | 76 |
|
|
2018
Q3 | $53K | Buy |
218
+1
| +0.5% | +$230 | 0.05% | 88 |
|
|
2018
Q2 | $45K | Hold |
217
| – | – | 0.04% | 90 |
|
|
2018
Q1 | $45K | Hold |
217
| – | – | 0.05% | 90 |
|
|
2017
Q4 | $41K | Buy |
+217
| New | +$41.6K | 0.04% | 97 |
|
Other funds holding TMO
Tower View Wealth Management's TMO Position: Q2 2026 in Review
Tower View Wealth Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 112 shares worth $56K. The position accounts for 0.02% of the portfolio, ranked #99.
Tower View Wealth Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $169K in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Tower View Wealth Management held 112 shares of Thermo Fisher Scientific worth $56K as of Q2 2026.
- Tower View Wealth Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.02% of Tower View Wealth Management's portfolio in Q2 2026, its #99 holding.
- Tower View Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Tower View Wealth Management's Thermo Fisher Scientific position peaked at $169K in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.